Zomedica Corp.
ZOMDF
$0.05
$0.014540.85%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.00M | 6.13M | 6.26M | 7.34M | 6.35M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.00M | 6.13M | 6.26M | 7.34M | 6.35M |
| Cost of Revenue | 1.94M | 1.77M | 2.15M | 2.26M | 1.99M |
| Gross Profit | 5.06M | 4.36M | 4.12M | 5.07M | 4.36M |
| SG&A Expenses | 10.66M | 11.90M | 12.73M | 13.36M | 9.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.44M | 15.17M | 16.65M | 18.73M | 12.30M |
| Operating Income | -7.44M | -9.04M | -10.39M | -11.39M | -5.95M |
| Income Before Tax | -6.72M | -24.07M | -9.33M | -21.95M | -2.41M |
| Income Tax Expenses | -27.00K | -143.00K | -166.00K | 459.00K | -1.92M |
| Earnings from Continuing Operations | -6.70M | -23.93M | -9.16M | -22.41M | -491.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.70M | -23.93M | -9.16M | -22.41M | -491.00K |
| EBIT | -7.44M | -9.04M | -10.39M | -11.39M | -5.95M |
| EBITDA | -5.41M | -7.07M | -8.46M | -9.52M | -4.35M |
| EPS Basic | -0.01 | -0.02 | -0.01 | -0.02 | 0.00 |
| Normalized Basic EPS | 0.00 | -0.01 | -0.01 | -0.01 | 0.00 |
| EPS Diluted | -0.01 | -0.02 | -0.01 | -0.02 | 0.00 |
| Normalized Diluted EPS | 0.00 | -0.01 | -0.01 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 979.95M | 979.95M | 979.95M | 979.95M | 979.95M |
| Average Diluted Shares Outstanding | 979.95M | 979.95M | 979.95M | 979.95M | 979.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
